Dr. Diba Kadivar | Inorganic Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Diba Kadivar | Inorganic Chemistry| Best Researcher Award

Dr. Diba Kadivar | Inorganic Chemistry| Ph. D. graduate in inorganic chemistry at chemistry and chemical engineering research center of iran , Iran

Dr. Diba Kadivar is a Ph.D. graduate in Inorganic Chemistry with extensive expertise in anticancer platinum complexes. She has been serving as a technical assistant at the Iranian Food and Drug Administration (IFDA) for over eight years, contributing to pharmaceutical research and regulatory affairs. Dr. Kadivar has conducted significant studies on the synthesis, characterization, and biological activity of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and aliphatic N-substituted glycine derivatives on platinum complexes’ pharmacological properties. She has published multiple papers in reputed journals and actively collaborates on cancer cell line studies. Passionate about innovative drug discovery, she has contributed to the development of metal-based nanocomplexes for potential therapeutic applications. Dr. Kadivar remains committed to advancing medicinal inorganic chemistry through her research and collaborations, aiming to enhance the effectiveness of anticancer therapies while minimizing side effects.

Professional Profile :         

Google Scholar

Orcid

Scopus  

Summary of Suitability for Award:

Dr. Diba Kadivar is a distinguished researcher in inorganic chemistry, specializing in anticancer platinum complexes. With a Ph.D. in inorganic chemistry and eight years of experience as a technical assistant at the Iranian Food and Drug Administration (IFDA), she has made notable contributions to the development of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and the role of aliphatic N-substituted glycine derivatives in enhancing the biological activities of platinum complexes. She has published in reputable journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications, with a citation index of 18. Dr. Diba Kadivar’s innovative research on platinum-based anticancer drugs, scientific contributions, and expertise in inorganic medicinal chemistry make her highly suitable for the “Best Researcher Award.” Her work advances cancer treatment strategies, and her publications demonstrate scientific excellence and impact in medicinal chemistry.

🎓Education:

Dr. Diba Kadivar pursued her doctoral studies in Inorganic Chemistry, specializing in metal-based drug development and anticancer platinum complexes. Her academic journey has been marked by a strong foundation in medicinal chemistry, with a keen interest in exploring the role of isomerism in drug efficacy. During her Ph.D., she conducted extensive research on platinum complexes with glycine derivatives, focusing on their interaction with DNA and anticancer properties. Her work involved molecular docking, dynamic simulations, and in-vitro studies to evaluate the pharmacological potential of these compounds. Through her research, she contributed to the field of coordination chemistry and its applications in medicine. She has actively participated in international conferences, presenting her findings on novel platinum-based therapies. With a passion for drug discovery, Dr. Kadivar continues to apply her expertise in chemistry to enhance the effectiveness of anticancer agents.

🏢Work Experience:

Dr. Diba Kadivar has accumulated over eight years of professional experience as a technical assistant at the Iranian Food and Drug Administration (IFDA). In this role, she has been actively involved in regulatory affairs, pharmaceutical analysis, and drug quality control, ensuring the safety and efficacy of therapeutic compounds. Alongside her administrative responsibilities, she has played a vital role in cancer research, working in laboratory settings to study platinum-based anticancer agents. Her expertise extends to working with cancer and normal cell lines, contributing to drug screening and cytotoxicity assays. Additionally, she has been involved in synthesizing and characterizing novel platinum complexes, focusing on their pharmacological interactions. Dr. Kadivar also collaborates with academic institutions and research centers, aiming to bridge the gap between regulatory science and drug discovery. Her hands-on experience in both research and regulatory affairs makes her a key contributor to pharmaceutical advancements in Iran.

🏅Awards: 

Dr. Diba Kadivar has been recognized for her contributions to inorganic and medicinal chemistry, particularly in the field of platinum-based anticancer research. She has received accolades for her pioneering work on the role of geometric isomerism in anticancer drug efficacy. Her research has been acknowledged at national and international scientific conferences, where she has been invited as a speaker and presenter. She has also played a key role in regulatory initiatives at the Iranian Food and Drug Administration, contributing to drug quality assurance and research-based policy-making. Additionally, her publications in esteemed journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications have received notable citations, highlighting her impact on the field. Dr. Kadivar’s dedication to advancing cancer therapy and pharmaceutical sciences continues to earn her recognition among her peers, further solidifying her reputation as an innovative researcher in medicinal inorganic chemistry.

🔬Research Focus:

Dr. Diba Kadivar’s research primarily revolves around the synthesis, characterization, and biological evaluation of platinum-based anticancer complexes. She investigates the impact of geometric isomerism on drug efficacy, focusing on how structural variations influence DNA interactions and cytotoxicity. Her studies explore novel ligand designs, particularly aliphatic N-substituted glycine derivatives, to enhance the pharmacological properties of platinum complexes. In addition to drug synthesis, she conducts in-vitro studies on cancer and normal cell lines to assess the cytotoxic potential of these compounds. She is also involved in molecular docking and dynamic simulations to predict drug interactions at the molecular level. Furthermore, she has worked on calcium, magnesium, copper, and zinc glycine edible nanocomplexes, aiming to develop biocompatible metal-based therapies. Through her interdisciplinary approach, Dr. Kadivar contributes to bridging chemistry and medicine, paving the way for new, targeted anticancer treatments with improved therapeutic outcomes.

Publication Top Notes:

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

Authors: K. Nikoofar, D. Kadivar, S. Shirzadnia

Citations: 13

Year: 2014

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Authors: D. Kadivar, M. E. Moghadam, B. Notash

Citations: 5

Year: 2024

Novel anticancer agents, Pt complex with 1-pyrrolidineacetic acid ligand: Synthesis, biological activity, DNA interaction, molecular docking, and dynamic study

Authors: D. Kadivar, M. E. Moghadam, M. Rezaeisadat

Year: 2025

 

Athanassios Philippopoulos | Inorganic Chemistry | Best Researcher Award

Posted on by sciencefather

Assoc Prof Dr. Athanassios Philippopoulos | Inorganic Chemistry | Best Researcher Award

Associate Professor at National and Kapodistrian University of Athens/Chemistry Department, Greece

Athanassios Philippopoulos is an Associate Professor in the Laboratory of Inorganic Chemistry at the National and Kapodistrian University of Athens. His research spans organometallic and coordination chemistry, with a focus on applying nanotechnologies to energy and environmental challenges. Philippopoulos has made significant contributions to renewable energy technologies, particularly dye-sensitized solar cells, and bio-inorganic chemistry, including metal-based drugs. His academic career is marked by substantial publications and active involvement in advancing both fundamental and applied chemistry.

Author Metrics

Scopus Profile

ORCID Profile

Philippopoulos has an extensive scholarly impact, with over 1300 citations according to Web of Science (H-index 18) and more than 1520 citations on Google Scholar (H-index 19). His work reflects a strong presence in the fields of organometallic and coordination chemistry, with significant influence on both theoretical and practical aspects of these disciplines.

Education

Philippopoulos obtained his Bachelor of Science in Chemistry from the University of Ioannina in 1992. He continued his studies at the same institution, completing his Ph.D. in Inorganic-Organometallic Chemistry in 1997. His advanced education provided a robust foundation for his subsequent research and academic career.

Research Focus

Philippopoulos’s research encompasses several key areas: organometallic and coordination chemistry, nanotechnologies for energy and environmental applications, and bio-inorganic chemistry. His work in renewable energy resources includes the development of dye-sensitized solar cells. Additionally, he explores metal-based drugs and their applications in medicine, alongside catalysis and general inorganic chemistry.

Professional Journey

Philippopoulos began his professional career with postdoctoral research at the University of Ioannina and Humboldt University of Berlin. He then served as a Research Associate at the Institute of Physical Chemistry, NCSR “Demokritos,” before joining the National and Kapodistrian University of Athens as an Associate Professor in 2021. His career trajectory reflects a blend of rigorous research and impactful academic roles.

Honors & Awards

Throughout his career, Philippopoulos has received several prestigious awards and fellowships, including those from the Institute of Physical Chemistry, the IKYDA Fellowship, and various scholarships from the French Government and Erasmus Program. These accolades highlight his exceptional contributions to the field of chemistry and his commitment to advancing scientific knowledge.

Publications Noted & Contributions

Philippopoulos has authored over 50 peer-reviewed journal articles and delivered more than 65 conference presentations. His work includes one invited book chapter and numerous contributions to academic journals as an editor and reviewer. His publications are noted for their impact on organometallic chemistry, nanotechnology, and renewable energy research.

Ruthenium <i>p</i>-Cymene Complexes Incorporating Substituted Pyridine–Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties

Publication Details:
Journal: Molecules
Date: July 2024
DOI: 10.3390/molecules29133215
Role: Author
Contributors: Afroditi Kokkosi, Elpida Garofallidou, Nikolaos Zacharopoulos, Nikolaos Tsoureas, Konstantina Diamanti, Nikolaos S. Thomaidis, Antigoni Cheilari, Christina Machalia, Evangelia Emmanouilidou, Athanassios Philippopoulos

This article explores the synthesis and characterization of ruthenium <i>p</i>-cymene complexes with substituted pyridine-quinoline ligands. It examines their potential cytotoxic properties, contributing to the field of metal-based anticancer agents.

Anti-Inflammatory and Antithrombotic Potential of Metal-Based Complexes and Porphyrins

Publication Details:
Journal: Compounds
Date: June 2024
DOI: 10.3390/compounds4020023
Role: Author
Contributors: Alexandros Tsoupras, Sofia Pafli, Charilaos Stylianoudakis, Kalliopi Ladomenou, C.A. Demopoulos, Athanassios Philippopoulos

This study evaluates the anti-inflammatory and antithrombotic activities of various metal-based complexes and porphyrins. The findings offer insights into their therapeutic potential for cardiovascular and inflammatory diseases.

First-Row Transition Metal Complexes Incorporating the 2-(2′-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin

Publication Details:
Journal: Molecules
Date: October 2023
DOI: 10.3390/molecules28196899
Role: Author
Contributors: Antigoni Margariti, Vasiliki D. Papakonstantinou, George Stamatakis, C.A. Demopoulos, Christina Machalia, Evangelia Emmanouilidou, Gregor Schnakenburg, Maria-Christina Nika, Nikolaos S. Thomaidis, Athanassios Philippopoulos

The paper focuses on the cytotoxic effects and biological activities of first-row transition metal complexes with 2-(2′-pyridyl)quinoxaline ligands. It investigates their role as inflammatory mediators and their impact on platelet-activating factors and thrombin.

Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(<i>η</i><sup>5</sup>-C<sub>5</sub>R<sub>5</sub>)Co{P(OEt)<sub>2</sub>O}<sub>3</sub>]<sup>−</sup>, (R = H, Me; Et = -C<sub>2</sub>H<sub>5</sub>) as Potent Inflammatory Mediator Inhibitors: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin

Publication Details:
Journal: Molecules
Date: February 2023
DOI: 10.3390/molecules28041859
Role: Author
Contributors: Alexandros Kalampalidis, Artemis Damati, Demetrios Matthopoulos, Alexandros Tsoupras, C.A. Demopoulos, Gregor Schnakenburg, Athanassios Philippopoulos

This article investigates the cytotoxic properties and biological activities of tin(II) and tin(IV) complexes with oxygen tripodal ligands. It highlights their effectiveness as inhibitors of inflammatory mediators like PAF and thrombin.

Sterically Demanding Pyridine-Quinoline Anchoring Ligands as Building Blocks for Copper(<scp>i</scp>)-Based Dye-Sensitized Solar Cell (DSSC) Complexes

Publication Details:
Journal: Dalton Transactions
Date: 2022
DOI: 10.1039/d2dt02382b
Role: Author
Contributors: Anastasios Peppas, Demetrios Sokalis, Dorothea Perganti, Gregor Schnakenburg, Polycarpos Falaras, Athanassios Philippopoulos

This publication discusses the use of sterically demanding pyridine-quinoline ligands in designing copper(I)-based dye-sensitized solar cells. It contributes to the development of advanced materials for solar energy applications.

Research Timeline

Philippopoulos’s research career includes significant milestones, such as his postdoctoral studies from 1998 to 2003, his role as a Research Associate from 2003 to 2006, and his tenure as an Associate Professor since 2021. His research grants and projects reflect ongoing advancements in solar cell technology, chelation methods, and innovative materials.

Collaborations and Projects

Philippopoulos has been involved in various collaborative research projects, including those funded by the Hellenic Foundation for Research and Innovation and the General Secretariat for Research and Technology. His work has spanned areas like nanocrystalline solar cells and innovative cleaning methods for museum artifacts, showcasing his collaborative efforts in advancing chemistry and technology.

Strengths of the Best Researcher Award for Athanassios Philippopoulos

  1. Significant Scholarly Impact: Philippopoulos has made notable contributions to the fields of organometallic and coordination chemistry, with over 1300 citations on Web of Science and 1520 on Google Scholar. This indicates a strong influence and recognition of his work within the scientific community.
  2. Diverse Research Areas: His research spans several crucial areas, including renewable energy (dye-sensitized solar cells), bio-inorganic chemistry (metal-based drugs), and nanotechnologies. This broad focus demonstrates his versatility and impact across multiple subfields of chemistry.
  3. High-Quality Publications: Philippopoulos has published over 50 peer-reviewed journal articles and contributed to significant research outputs, such as studies on ruthenium complexes, metal-based drugs, and copper(I)-based dye-sensitized solar cells. This reflects his commitment to advancing scientific knowledge and addressing pressing challenges.
  4. Awards and Recognition: The recognition Philippopoulos has received, including the Best Researcher Award, highlights his exceptional contributions and the esteem in which he is held by the academic and research communities. His past honors from various prestigious institutions further validate his achievements.
  5. Active Academic Engagement: Philippopoulos’s role in numerous conference presentations and his involvement as an editor and reviewer for academic journals show his active engagement in the scientific community. This participation underscores his dedication to both research and the dissemination of knowledge.

Areas for Improvement

  1. Broader Research Collaborations: While Philippopoulos has been involved in several collaborative projects, expanding his network to include more international and interdisciplinary collaborations could enhance the scope and impact of his research.
  2. Interdisciplinary Integration: There is an opportunity to further integrate his research with other scientific disciplines, such as materials science or environmental engineering, to address complex challenges from multiple perspectives.
  3. Increased Public Outreach: Enhancing efforts to communicate his research findings to the general public and stakeholders outside the academic community could increase the societal impact and relevance of his work.
  4. Funding and Grants: While Philippopoulos has been involved in research funded by various grants, seeking additional funding opportunities or leading larger-scale, multi-institutional projects could provide more resources for ambitious research goals.
  5. Educational Contributions: Developing and incorporating innovative teaching methods or educational programs related to his research areas could further benefit students and early-career researchers, enriching the academic environment at his institution.

Conclusion

Athanassios Philippopoulos has made substantial contributions to inorganic chemistry, particularly in the areas of organometallic chemistry, renewable energy, and bio-inorganic chemistry. His extensive publication record, significant citations, and numerous awards reflect his outstanding research accomplishments and impact on the field. While there are areas for potential improvement, such as broadening collaborations and enhancing public outreach, his achievements and ongoing contributions position him as a leading figure in his field. The Best Researcher Award is a testament to his dedication and excellence in advancing scientific knowledge and addressing global challenges through chemistry.